University Chemistry ›› 2023, Vol. 38 ›› Issue (7): 152-156.doi: 10.3866/PKU.DXHX202208057

Special Issue:

• Science Education • Previous Articles     Next Articles

A Television Interview with Paxlovid

Minghong Yang1,2, Hongjian Lu2, Zhen Shen2, Kin Shing Chan2,*()   

  1. 1 Anbang Academy, College of First-Year Students, Nanjing University, Nanjing 210023, China
    2 School of Chemistry and Chemical Engineering, Nanjing University, Nanjing 210023, China
  • Received:2022-08-09 Accepted:2022-09-27 Published:2022-12-07
  • Contact: Kin Shing Chan E-mail:kschan@nju.edu.cn

Abstract:

Because its ability to treat COVID-19, Paxlovid, the leader of "Paxlovid" antiviral team, was interviewed by the Medication TV station and its interactions with other drugs in the SARS-CoV-2 treatment were discussed.

Key words: Ritonavir, Nirmatrelvir, SARS-CoV-2, Mechanism of action